This transcript has been edited for clarity. Gayatri Acharya, MD: Greetings. I'm Dr Gayatri Acharya, cardiology fellow at Mayo Clinic. During today's roundtable, we'll be discussing cardiac ...
Isis Pharmaceuticals, Inc. ISIS announced encouraging data from an ongoing open-label extension (OLE) study on ISIS-TTR for the treatment of patients suffering from familial amyloid polyneuropathy ...
Transthyretin amyloidosis, also called ATTR amyloidosis, is a life-threatening disease characterized by progressive accumulation of misfolded transthyretin (TTR) protein in tissues, predominantly the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback